SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000880771-17-000022
Filing Date
2017-02-28
Accepted
2017-02-28 16:04:36
Documents
3
Period of Report
2017-02-28
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K scln-20170228x8k.htm 8-K 28026
2 EX-3.1 scln-20170228xex3_1.htm EX-3.1 14966
3 EX-3.2 scln-20170228xex3_2.htm EX-3.2 175369
  Complete submission text file 0000880771-17-000022.txt   219533
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19825 | Film No.: 17647578
SIC: 2834 Pharmaceutical Preparations